Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival

Transplantation

Volumn 81, Issue 2, 2006, Pages 240-246

  Vassalli, Giuseppe ^a   Simeoni, Eleonora ^a   Jian, Ping Li ^a,b   Fleury, Sylvain ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Chemokines antagonist; Gene therapy; Graft rejection; Heart transplantation; Lentivirus vector

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; RANTES; RANTES[9-68]PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; RANTES (9 68); RANTES (9-68); RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG POTENCY; EMBRYO; EX VIVO STUDY; GENE TRANSFER; GENETIC CODE; GENETIC TRANSDUCTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LENTIVIRUS VECTOR; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECIPIENT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ALLOTRANSPLANTATION; ANIMAL; CELL LINE; DRUG ANTAGONISM; FISCHER 344 RAT; GENE THERAPY; GENETICS; IMMUNOLOGY; LENTIVIRINAE; LEWIS RAT; METABOLISM; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA, COMPLEMENTARY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; HEART TRANSPLANTATION; HUMANS; LENTIVIRUS; MALE; RANTES; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644849955     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000194859.98504.9e     Document Type: Article

References (28)

1. Hancock WW. Chemokines receptor-dependent alloresponses. Immunol Rev 2003; 196: 37.
2. Horuk R, Clayberger C, Krensky AM, et al. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem 2001; 276: 4199.
3. Gao W, Faia KL, Csizmadia V, et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001; 72: 1199.
4. Gao W, Topham PS, King JA, et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105: 35.
5. Belperio JA, Burdick MD, Keane MP, et al. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J Immunol 2000; 165: 461.
6. Segerer S, Cui Y, Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518.
7. Fahmy NM, Yamani MH, Starling RC, et al. Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 2003; 75: 72.
8. Azzawi M, Hasleton PS, Geraghty PJ, et al. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages. J Heart Lung Transplant 1998; 17: 881.
9. Guillot C, Mathieu P, Coathalem H, et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000; 164: 5258.
10. Gong JH, Uguccioni M, Dewald B, et al. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 1996; 271: 10521.
11. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463.
12. Follenzi A, Ailles LE, Bakovic S, et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25: 217.
13. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886.
14. Fleury S, Simeoni E, Zuppinger C, et al. Multiply attenuated, selt-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation 2003; 107: 2375.
15. Lizee G, Aerts JL, Gonzales MI, et al. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 2003; 14: 497.
16. Applied Biosystems. Relative quantification of gene expression. User bulletin No. 2. Foster City, CA: PE, Applied Biosystems, 1997.
17. Fleury S, Driscoll R, Simeoni E, et al. Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors. Basic Res Cardiol 2004; 99: 247.
18. Ogilvie P, Paoletti S, Clark-Lewis I, Uguccioni M. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 2003; 102: 789.
19. Hadida F, Vieillard V, Autran B, et al. HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 1998; 188: 609.
20. Ylisastigui L, Vizzavona J, Drakopoulou E, et al. Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages. AIDS 1998; 12: 977.
21. Signoret N, Pelchen-Matthews A, Mack M, Proudfoot AEI. Endocytosis and recycling of the HFV coreceptor CCR5. J Cell Biol 2000; 151: 1281.
22. Horuk R, Shurey S, Ng HP, et al. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett 2001; 76: 193.
23. Grone HJ, Weber C, Weber KS, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 1999; 13: 1371.
24. Bedke J, Stojanovic T, Grone HJ, et al. Met-RANTES improves acute-rejection-induced microvascular injury in rat small bowel transplantation. Transplant Proc 2002; 34: 1049.
25. Fu S, Chen D, Mao X, et al. Feline immunodeficiency virus-mediated viral interleukin-10 gene transfer prolongs non-vascularized cardiac allograft survival. Am J Transplant 2003; 3: 552.
26. Zhao J, Pettigrew GJ, Thomas J, et al. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol 2002; 97: 348.
27. Zhao J, Pettigrew GJ, Bolton EM, et al. Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection. Gene Ther 2005; 12: 1509.
28. Hofmann W, Schubert D, LaBonte J, et al. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 1999; 73: 10020.